 |
| Prostate cancer chart worldwide |
The U.S. Preventive Services Task Force issued its final report on Monday 21st may 2012, recommending against prostate-specific antigen (PSA) screening for prostate cancer for men of any age. Why?
Very few men actually need treatment to survive and the side effects from prostate cancer treatment do more harm than good, the task force concluded.
The report goes thus,
Prostate cancer is the most commonly diagnosed non-skin cancer in men in the United States, with a lifetime risk for diagnosis currently estimated at 15.9%. Most cases of prostate cancer have a good prognosis even without treatment, but some cases are aggressive; the lifetime risk for dying of prostate cancer is 2.8%. Prostate cancer is rare before age 50 years, and very few men die of prostate cancer before age 60 years. Seventy percent of deaths due to prostate cancer occur after age 75 years. There is adequate evidence that the benefit of PSA screening and early treatment ranges from 0 to 1 prostate cancer deaths avoided per 1000 men screened.
No comments:
Post a Comment